What is the best predictor of severity of acute pancreatitis?

CRP as a Key Indicator in Assessing Acute Pancreatitis Severity

When it comes to managing acute pancreatitis (AP), one of the most critical challenges is determining how severe the condition will become early in its course. Among the various markers clinicians rely on, C-reactive protein (CRP) stands out as one of the most practical and widely used predictors.

CRP, a protein produced by the liver in response to inflammation, typically rises within the first 24 hours after the onset of symptoms and peaks around 48 hours. Research shows that measuring CRP at this 48-hour mark can provide valuable insight into the likely progression of the disease. A level exceeding 150 mg/L is commonly used as a cutoff to differentiate between mild and severe forms of acute pancreatitis.

Studies have found this threshold offers a sensitivity of 86% and a specificity of 61%, making it a reasonably reliable tool—especially in clinical settings where more complex scoring systems or imaging may not be immediately available. While CRP alone doesn’t provide a complete picture, it’s a cost-effective, accessible indicator that helps guide decisions about hospitalization, monitoring, and intervention.

It’s worth noting that while CRP is useful, it’s not infallible. Other factors—such as organ failure, age, and comorbidities—also play a crucial role in prognosis. However, the simplicity and timing of CRP measurement make it a cornerstone in early risk stratification.

In everyday practice, a rapidly rising CRP level beyond 150 mg/L often raises a red flag, prompting closer observation and more aggressive supportive care. So while no single marker is perfect, CRP remains a trusted ally in navigating the uncertainty of acute pancreatitis.